Match Document Document Title
US20150191756 METHOD FOR PRODUCING METHACRYLIC ACID AND/OR ESTER THEREOF  
To provide a method for directly and efficiently producing methacrylic acid in a single step from renewable raw materials and/or biomass arising from the utilization of the renewable raw...
US20120088300 COMPOSITIONS AND METHODS FOR PROMOTING THE GENERATION OF DEFINITIVE ENDODERM  
Certain embodiments disclosed herein are directed to a method of producing endoderm cells, such as definitive endoderm cells by exposing stem cells such as embryonic stem cells or induced...
US20120322873 USE OF A BUFFER WITH A BIOCIDE PRECURSOR  
Disclosed herein are biocidal compounds and compositions, methods of using said compounds and compositions, and systems and processes for their preparation. Particularly disclosed herein are in...
US20130253004 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT FIBROSIS  
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as...
US20120108419 ABSORBENT CORE  
An absorbent core for an absorbent article comprising from 1 to 2000 mg of a not cross linked polycarboxylic acid based polymer having an average molecular weight between 1000 and 25000 Da.
US20140094438 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN  
The claimed invention relates to compositions that may be in a form of a liquid, solid, gel, cream or gel capsule comprising an analgesic, and methods for administering these compositions for...
US20090252676 N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS  
The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides...
US20140242867 LIGNIN COMPOSITIONS, METHODS OF PRODUCING THE COMPOSITIONS, METHODS OF USING LIGNIN COMPOSITIONS, AND PRODUCTS PRODUCED THEREBY  
Lignin compositions, products produced from them or containing them, methods to produce them, spinning methods, methods to convert lignin to a conversion product and conversion products produced...
US20140050810 ANTI-OBESITY COMPOSITION COMPRISING LYCIUM CHINENSIS LEAF EXTRACT AND BETAINE AS ACTIVE INGREDIENT  
Disclosed are betaine and a Lycium chinensis leaf extract and a mixture thereof which are preventive and therapeutic of obesity, and uses thereof. They are found to have prophylactic and...
US20120271065 METHOD FOR RECOVERING ANIONIC FLUORINATED EMULSIFIER  
To provide a method for recovering an anionic fluorinated emulsifier, capable of easily and efficiently recovering an anionic fluorinated emulsifier adsorbed on a basic ion exchange resin. A basic...
US20140024635 INHIBITORS OF THE INFLUENZA A VIRUS M2 PROTON CHANNEL  
Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza...
US20120028957 Inhibitors Of The Influenza A Virus M2 Proton Channel  
Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza...
US20120295812 METHOD FOR EXTRACTING STAPHYLOCOCCUS AUREUS ANTIGEN, REAGENT FOR EXTRACTING STAPHYLOCOCCUS AUREUS ANTIGEN, AND METHOD FOR ASSESSING STAPHYLOCCOCCUS AUREUS  
The invention provides a method for extracting a Staphylococcus aureus antigen which comprises using an extraction reagent with a pH of no higher than 5.0, containing one or more acids selected...
US20110118353 METHOD OF HORMONE SUPPRESSION IN HUMANS  
The present invention relates to a glycine transporter-1 inhibitor having the formula (I) wherein X is 1-3 substituents selected from H, halogen, methyl, methoxy, trifluoromethyl and...
US20130197079 MGLU 2/3 AGONISTS  
The present invention provides novel mGlu2/3 agonists useful in the treatment of neurological or psychiatric disorders.
US20110237676 SPERMICIDAL AND MICROBICIDAL COMPOSITIONS  
Provided herein are new spermicidal compositions that include one or more fluorous surfactants, e.g., non-ionic fluorous surfactants, anionic fluorous surfactants, cationic fluorous surfactants,...
US20120083531 CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING  
The present invention relates to pharmaceutical compositions suitable for inhalation, comprising as an active ingredient calcium lactate or calcium citrate. The invention also relates to methods...
US20150011453 OILFIELD CLEANER AND CORROSION INHIBITOR  
Disclosed herein are cleaner/corrosion inhibiting compositions useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also...
US20140058132 METHOD FOR PRODUCING ACETYLENEDICARBOXYLIC ACID FROM ACETYLENE AND CARBON DIOXIDE  
The invention relates to a method for producing acetylenedicarboxylic acid by reaction of acetylene with carbon dioxide, wherein the reaction is carried out in the presence of a silver or copper...
US20090285786 METHOD TO MODULATE HEMATOPOIETIC STEM CELL GROWTH  
The present invention provides for compositions and methods for modulating hematopoietic stem cell populations by using HCS modulators, which are agents that either increase HSC numbers or...
US20140350298 PROCESS FOR THE (AMM)OXIDATION OF LOWER MOLECULAR WEIGHT ALKANES AND ALKENES  
A process for producing unsaturated carboxylic acids or unsaturated nitriles by vapor phase oxidation reaction of their corresponding C3 to C5 alkanes, C3 to C5 alkenes, and mixtures thereof, as a...
US20090074691 Topical Delivery System for Antiaging and Skin Whitening Agents  
This invention relates to certain hydroxyaryl alkanols, alkyl amines, alkyl amino acids, alkyl amino esters, and alkyl amino alkanols (“Hydroxyaryl compounds”) of formula (I). A method of topical...
US20150119601 MONOFUNCTIONAL MCR + 3-HP DEHYDROGENASE  
The present invention provides various combinations of genetic modifications to a transformed host cell that provide increase conversion of carbon to a chemical product. The present invention also...
US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists  
A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of a carbohydrate; or said prodrug is an ester, ether, or amide of an amino acid...
US20140336409 PROCESS FOR PREPARING AN INTERNAL OLEFIN SULFONATE  
The invention relates to a process for preparing an internal olefin sulfonate, comprising sulfonating an internal olefin into sulfonated internal olefin followed by contacting sulfonated internal...
US20120193574 Method Of Controlling Crystallization  
The invention provides a method of crystallising a compound comprising either: (i) providing a first confined solution comprising the compound; and adding more of the compound to and/or increasing...
US20140308720 PROCESSES FOR PRODUCING LEVULINIC ACID FROM BIOMASS  
This invention provides processes to convert biomass, including wood and agricultural residues, to levulinic acid and co-products. Some variations treat feedstock with steam and/or hot water to...
US20110201841 OXIDATIVE MONO-HALOGENATION OF METHANE  
Oxidatively halogenate methane by placing a feedstream that comprises methane, a source of halogen, a source of oxygen and, optionally, a source of diluent gas in contact with a first catalyst...
US20110152222 USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF ARTHRITIS AND PAIN  
The present invention relates to the use of a compound of Formula (I′″) or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the...
US20120277176 Protein Arginine Deiminase Inhibitors as Novel Therapeutics for Rheumatoid Arthritis and Cancer  
In accordance with certain embodiments of the present disclosure, a self-assembling biodegradable nanoparticle is provided. The nanoparticle includes Cys-Val-Val-Val-Val-Val-Val-Lys-Lys conjugated...
US20110319661 PROCESS FOR PRODUCING (METH) ACRYLIC ACID  
A process for producing (meth)acrylic acid of the present invention comprises the steps in the following order: a crystallization step of supplying a cooling medium cooled by a heat source device...
US20130000209 FUNCTIONALIZED MICROSCALE DIAMOND PARTICLES AND RELATED STRUCTURES AND METHODS  
Methods of treating a plurality of particles comprise functionalizing a plurality of microscale diamond particles by covalently bonding one or more molecular groups selected from the group...
US20140094455 AQUAPORIN MODULATORS AND METHODS OF USING THEM FOR THE TREATMENT OF EDEMA AND FLUID IMBALANCE  
Compounds, including 3-carboxy aryl sulfonamide compounds, which agonize or antagonize aquaporin channels and methods of using them to treat disorders or diseases mediated by aquaporins.
US20110178175 METHOD FOR PRODUCING MECHANICALLY ACTIVATED AMORPHOUS AND AMORPHOCRYSTALLINE COMPOUNDS OF GLUCONIC ACID CALCIUM SALT  
The invention relates to the creation of mechanically activated amorphous and amorphocrystalline compounds and compositions of a gluconic acid calcium salt, pharmaceutical preparations based...
US20150087861 METHOD FOR PRODUCING ACROLEIN AND/OR ACRYLIC ACID FROM GLYCEROL  
The invention relates to the production of acrolein and/or acrylic acid from glycerol, and more particularly to a method for continuous production of a stream comprising acrolein by dehydration of...
US20060281947 (Meth) acrylic acid composition and method for producing the same  
The present invention removes impurities inhibiting storage stability of (meth)acrylic acid or stability in polymerization of (meth)acrylic acid when (meth)acrylic acid is used as a raw material,...
US20130108560 Chemical Treatments for the Disruption of Dental Plaque Biofilms and Related Methods  
A thin film composition for oral administration that adheres to and dissolves in a mouth of a user, wherein the thin film is a single layered water-soluble solid comprising at least one D-amino...
US20120322717 Compounds and assays for controlling Wnt activity  
The present invention relates to the field of therapeutic methods to screen for compounds on the basis of their ability to influence Wnt activity. The screening process is applied to both a...
US20100298200 Compounds and assays for controlling Wnt activity  
The present invention relates to the field of therapeutic methods to screen for compounds on the basis of their ability to influence Wnt activity. The screening process is applied to both a...
US20090221464 PROCESS TO OBTAIN A HIGHLY SOLUBLE LINEAR ALKYLBENZENE SULFONATE  
The present invention refers to a process to obtain a highly soluble linear alkylbenzene sulfonate (LAS). Specifically it comprises the addition, prior or after sulfonation of linear alkylbenzene...
US20050250849 Basic amino acid - methionine hydroxy analog compositions  
Simple, cost-effective and convenient compositions comprising basic amino acids and 2-hydroxy-4-methylthiobutanoic acid (HMBA) are disclosed. The compositions have many uses, including as food...
US20140142189 METHIONINE ANALOGS AND METHODS OF USING SAME  
Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit...
US20110196014 METHIONINE ANALOGS AND METHODS OF USING SAME  
Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit...
US20110160482 CATALYSTS FOR HYDRODEOXYGENATION OF POLYOLS  
Disclosed are methods for producing polyols, ketones, carboxylic acids, aldehydes and alcohols from biomass-derived oxygenated hydrocarbons, such as sugars, sugar alcohols, saccharides and the...
US20080293764 LPA RECEPTOR ANTAGONIST  
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence...
US20090163380 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY  
A novel affinity capture surface, as well as methods of using and making the affinity capture surface and sample presentation devices or biochips comprising the affinity capture surface, are...
US20090068440 PRODUCTION OF ACROLEIN, ACRYLIC ACID AND WATER-ABSORBENT POLYMER STRUCTURES MADE FROM GLYCERINE  
The present invention relates to a process for the production of acrolein, comprising the following steps: (a) bringing into contact of an aqueous glycerine phase in an acrolein reaction area to...
US20140041690 Synthetic Acid and Associated Methods  
Glycine is an organic compound that can be used in the making of a synthetic acid that obviates all the drawbacks of strong acids such as hydrochloric acid. The new compound is made by dissolving...
US20120046433 PROCESS FOR PRODUCING (METH)ACRYLIC ACID  
A process for producing (meth)acrylic acid, comprising a crystallizing step of supplying a cooling medium from a refrigerator to a crystallizer and returning the cooling medium from the...
US20100189781 ALKOXYALKYL S-PRENYLTHIOSALICYLATES FOR TREATMENT OF CANCER  
Disclosed are alkoxyalkyl S-prenylthiosalicylates and pharmaceutical compositions containing the same and a pharmaceutically acceptable carrier. Methods for treating a human afflicted with cancer,...